| Brawn Biotech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530207 |
NSE Symbol : - |
P/E(TTM) : 8.48 |
|
ISIN Demat : INE899B01015 |
Div & Yield% : 0.00 |
EPS(TTM) : 2.86 |
|
Book Value(₹) : 14.46 |
Market Cap(₹Cr) : 7.28 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 6.08 | 1.98 | 4.31 | 4.89 | 5.80 | 2.26 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 6.08 | 1.98 | 4.31 | 4.89 | 5.80 | 2.26 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.14 | 0.18 | 0.09 | 0.09 | 0.09 | 0.09 |
| Total Income | 6.22 | 2.16 | 4.40 | 4.98 | 5.89 | 2.35 |
| Total Expenditure | 6.03 | 2.48 | 4.32 | 4.88 | 5.62 | 2.81 |
| PBIDT | 0.18 | -0.32 | 0.08 | 0.10 | 0.27 | -0.46 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 0.18 | -0.33 | 0.08 | 0.10 | 0.27 | -0.46 |
| Depreciation | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Tax | 0.00 | -0.94 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 0.15 | 0.58 | 0.05 | 0.07 | 0.24 | -0.49 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.15 | 0.58 | 0.05 | 0.07 | 0.24 | -0.49 |
| EPS (Unit Curr.) | 0.52 | 1.95 | 0.17 | 0.25 | 0.89 | -1.65 |
| EPS (Adj) (Unit Curr.) | 0.52 | 1.95 | 0.17 | 0.25 | 0.89 | -1.65 |
| Calculated EPS (Unit Curr.) | 0.51 | 1.94 | 0.17 | 0.24 | 0.79 | -1.65 |
| Calculated EPS (Adj) (Unit Curr.) | 0.51 | 1.94 | 0.17 | 0.24 | 0.79 | -1.65 |
| Calculated EPS (Ann.) (Unit Curr.) | 2.06 | 7.78 | 0.66 | 0.95 | 3.15 | -6.59 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.06 | 7.78 | 0.66 | 0.95 | 3.15 | -6.59 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 2.96 | -16.16 | 1.86 | 2.04 | 4.66 | -20.35 |
| PBDTM(%) | 2.96 | -16.67 | 1.86 | 2.04 | 4.66 | -20.35 |
| PATM(%) | 2.47 | 29.29 | 1.16 | 1.43 | 4.14 | -21.68 |
